ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Observational Study |
Article Title |
Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study
|
Manuscript Source |
Invited Manuscript |
All Author List |
Lorenzo Norsa, Pietro Andrea Bonaffini, Maja Caldato, Cristiana Bonifacio, Aurelio Sonzogni, Amedeo Indriolo, Clarissa Valle, Federica Furfaro, Alice Bonanomi, Paolo Niccolò Franco, Mauro Gori, Veronica Smania, Lucia Scaramella, Laura Forzenigo, Maurizio Vecchi, Monica Solbiati, Giorgio Costantino, Silvio Danese, Lorenzo D'Antiga, Sandro Sironi and Luca Elli |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Lorenzo Norsa, PhD, Doctor, Doctor, Department of Pediatric Gastroenterology Hepatology and Transplantation, ASST Papa Giovanni XXIII, Piazza OMS 1, Bergamo 24127, Italy. lnorsa@asst-pg23.it |
Key Words |
Coronavirus; COVID-19; Ischemic colitis; Small bowel ischemia; Endothelial inflammation |
Core Tip |
Ischemic manifestations have been described as possible presenting symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These manifestations are frequent in the respiratory tract and bear a high fatality rate. Our retrospective observational trial aims to describe the prevalence, the characteristics and the evolution of patients presenting with intestinal ischemic manifestations of SARS-CoV-2 infection. |
Publish Date |
2021-08-25 02:11 |
Citation |
Norsa L, Bonaffini PA, Caldato M, Bonifacio C, Sonzogni A, Sonzogni A, Valle C, Furfaro F, Bonanomi A, Franco PN, Gori M, Smania V, Scaramella L, Forzenigo L, Vecchi M, Solbiati M, Costantino G, Danese S, D'Antiga L, Sironi S, Elli L. Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study. World J Gastroenterol 2021; 27(32): 5448-5459 |
URL |
https://www.wjgnet.com/1007-9327/full/v27/i32/5448.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v27.i32.5448 |